HubXchange - CNS Therapeutics Xchange Europe 2021 – 2nd December 2021
With preclinical/clinical transition being the largest failure risk in CNS therapeutics development, join us at HubXchange’s CNS Therapeutics Europe 2021 roundtable meeting, where senior drug developers from pharma and biotech share experiences and discuss the future research landscape. Jack Prenderville, Head of Transpharmation Ireland, will be presenting a poster on our latest neuroinflammation studies. Join him between 3.10 – 3.40pm CET, December 2nd, under preclinical discussion.
For more information on this event: https://www.hub-xchange.com/xchanges/